स्वाइन फ़्लू , इन्फ़्लून्जियम और अन्य होम्योपैथिक औषधियाँ

Saturday 22 August, 2009

मिनेटेस डाट काम पर शेरी ने इन्फ़्लून्जियम पर कुछ रोचक आँकडॆ दिये ।  1918 से 1957 तक इस औषधि के स्त्रोत फ़्लू से ग्रस्त रोगियों के नासिक स्त्राव और  रक्त के सैम्पल से लिये गये । और  इनमे से अधिकतर उन रोगियों से जो 1918 के फ़्लू की महामारी से ग्रस्त थे ।

1957 के बाद से दवा बनाने के  ढंग  मे बदलाव आया और दवा का स्त्रोत फ़्लू वैक्सीन से लिया गया । इग्लैंड की नेलसन होम्यो लैब इसकी मुख्य निर्माता और विक्रेता हैं और 1918 से 1957  अब तक लगभग 13 अलग –2 सैम्पल ला चुके हैं । इनमे से अधिकतर सैम्पल इसके पूर्व वर्ष मे हुये फ़्लू के वैक्सीन  से लिये गये हैं । 1918 का फ़्लू वाइरस मुख्यत: H1N1 वाइरस था और यह अब तक के सबसे अधिक खतरनाक वाइरस की श्रेणी मे आता है । होम्योपैथिक दृष्टिकोण से मुख्य है इसकी प्रूविग जिससे उत्पन्न लक्षण लगभग वही थे जो फ़्लू के लक्षण से मेल खाते थे । नेलसन द्वारा  उत्पादित इन्फ़्लून्जियम के अन्य उत्पाद निम्म हैं :

1. *Influenzinum (the 1918 epidemic) *
1. 2. Influenza virus A Asia /57
1. 3. Influenza virus A England 42/72
1. 4. Influenza virus B Hong Kong 5/72
1. 5. Influenza virus A/Port Chalmers 1/73
1. 6. Influenza virus A (Asian) 1954
1. 7. Influenza virus B (Asian) 1954
1. 8. Bacillus influenza 1918
1. 9. Influenza virus Az Hong Kong 1968
1. 10. Influenza virus Ar 1967
1. 11. Influenza virus B
1. 12. Influenza Co. (Combination of Az to 1918)
1. 13. Influenza virus a1.

नेलसन लैब के एम्सवर्थ ने इन उत्पादन पर अपनी कुछ इस तरह टिप्पणी की ,

"Our 'Influenzinum' is a nosode but it is old. pre 1985.
All the others are made from vaccines except 1989 and triple nosode.
As the flu strains vary from year to year we make up fresh potencies
from the years 'most lightly flu's' vaccine each year in October".

लेकिन अपने देश मे कौन सा उत्पाद प्रयोग हो रहा है , इसके बारे मे दो प्रमुख कम्पनियाँ , बोइरोन इन्डिया और  श्वाबे इन्डिया ने भी अब तक कुछ खास जानकारी नही दी है ।

फ़्लू /स्वाइन /बर्ड /या आम फ़्लू से बचने के लिये इन्फ़्लूनिजियम प्रयोग करने का सही तरीका क्या है :

होम्योपैथिक दृष्टिकोण से  कोई फ़र्क नही पडता कि वह कौन सा फ़्लू है , स्वाइन / बर्ड / या आम फ़्लू , मुख्य है फ़्लू के लक्षणॊ का औषधि से मेल खाना  ।

इन्फ़्लूनिजियम नोसोड श्रेणी मे आता है और इसका व्यवहार भी  सावधानीपूर्वक करना चाहिये । इन्फ़्लूनिजियम 200 सपताह मे एक बार चार सप्ताह तक लगातार और इसके बाद महीने मे एक बार लें।

Influenzinum 200 c - take one dose every week for four weeks, and then, take the last dose one month later. This is intended as a strengthening/preventative measure

फ़्लू के लक्षण प्रकट होते ही किन औषधियों का प्रयोग करें :

  • ओसिलोकोकिनम या ऐनस बार्ब 200c : फ़्लू की शुरुआत होते ही इसका प्रयोग करें । फ़िलहाल अपने देश मे उपलब्धता  नही के बराबर है ।

Oscillococcinum aka Anas Barb 200c. There are two names for this remedy. It's Anas Barb in Nelsons. This is to be taken on the first onset of 'flu symptoms. It should catch the early onset of the 'flu. Though it’s not availbale in India .

  • चुनी हुई सही चयनित औषधि : होम्योपैथिक औषधि प्रयोग करने का यह तरीका सबसे कारगर और सही है । फ़्लू हो जाने पर सही चयनित औषधि का चयन किसी कुशल होम्योपैथिक चिकित्सक से करवायें और प्रयोग करें । इससे संबधित इस लेख को भी देखें ।

The Indicated Remedy if you actually get the full blown 'flu, then give the indicated 'flu remedy according to the symptoms. Here's a good guide: http://www.hpathy.com/diseases/Swine-flu-symptoms-treatment.asp

 आम प्रयोग होने वाली होम्योपैथिक औषधियाँ : लक्षण के अनुसार : [ मार्गेट टायेलेर की Pointers to the common Remedies देखें । ]

Aconite

Belladona

arsenic

Baptisia

Gelsemium

Eup Perf

Pyrogen

Bryonia

Rhus Tox

Mercurious

Camphor

Nux vom

AFTER INFLUENZA BADLY RECOVERED FROM

sulphur

china

arsenic

Cyprepedium pubescens

cyprepedin

Scutellaria lat

  • "genus epidemicus

[ चित्र को सफ़ और बडे आकार मे देखने के लिये किल्क करें ]

साभार : www.moleculardyne.com

माहामारियों मे दवा का चुनाव अन्य चुनाव की अपेक्षा आसान हो जाता है क्योंकि रोग के लक्षण लगभग एक से ही रह्ते हैं । और दवा का चुनाव  मुख्यत: एक या दो दवाओं पर आ टिकता  है ।  ऐसी अवस्था मे चयनित दवा को "genus epidemicus” कहते हैं । यही वजह थी कि 1918  के फ़्लू माहामारी मे होम्योपैथिक दवाओं से लाभ होने की संख्या अन्य पद्दतियों  की अपेक्षा कही अधिक थी ।

The indicated remedy in pandemics is usually very consistent and called the "genus epidemicus". This is narrowed down to a shortlist of three or less.

लेकिन क्या इन्फ़्लूजिनियम को "genus epidemicus” की श्रेणी मे डालना उचित है । हैनिमैन मुख्यत: इस तरह के चुनाव के पक्ष मे नही थे , कारण भले ही रोग का कारक एक ही हो लेकिन हर रोगी अपनी चारित्रिक विशेषताओं के होते हुये हर से भिन्न ही रहता है । "genus epidemicus” को लेकर हैनिमैन ने आर्गेनान मे कुछ विशेष निर्देश दिये हैं :

As per the guidelines laid down by Dr. Samuel Hahnemann in the Organon a Genus epidemics has to be found out in the specific area and it could be the best to be found out in the specific area and it could be the best prophylactic remedy.

    Source: ORGANON OF MEDICINE Aphorism 100-102

    § 100

    In investigating the totality of the symptoms of epidemic and sporadic diseases it is quite immaterial whether or not something similar has ever appeared in the world before under the same or any other name. The novelty or peculiarity of a disease of that kind makes no difference either in the mode of examining or of treating it, as the physician must any way regard to pure picture of every prevailing disease as if it were something new and unknown, and investigate it thoroughly for itself, if he desire to practice medicine in a real and radical manner, never substituting conjecture for actual observation, never taking for granted that the case of disease before him is already wholly or partially known, but always carefully examining it in all its phases; and this mode of procedure is all the more requisite in such cases, as a careful examination will show that every prevailing disease is in many respects a phenomenon of a unique character, differing vastly from all previous epidemics, to which certain names have been falsely applied – with the exception of those epidemics resulting from a contagious principle that always remains the same, such as smallpox, measles, etc.

    § 101

    It may easily happen that in the first case of an epidemic disease that presents itself to the physician’s notice he does not at once obtain a knowledge of its complete picture, as it is only by a close observation of several cases of every such collective disease that he can become conversant with the totality of its signs and symptoms. The carefully observing physician can, however, from the examination of even the first and second patients, often arrive so nearly at a knowledge of the true state as to have in his mind a characteristic portrait of it, and even to succeed in finding a suitable, homœopathically adapted remedy for it.

    § 102

    In the course of writing down the symptoms of several cases of this kind the sketch of the disease picture becomes ever more and more complete, not more spun out and verbose, but more significant (more characteristic), and including more of the peculiarities of this collective disease; on the one hand, the general symptoms (e.g., loss of appetite, sleeplessness, etc.) become precisely defined as to their peculiarities; and on the other, the more marked and special symptoms which are peculiar to but few diseases and of rarer occurrence, at least in the same combination, become prominent and constitute what is characteristic of this malady.1 All those affected with the disease prevailing at a given time have certainly contracted it from one and the same source and hence are suffering from the same disease; but the whole extent of such an epidemic disease and the totality of its symptoms (the knowledge whereof, which is essential for enabling us to choose the most suitable homœopathic remedy for this array of symptoms, is obtained by a complete survey of the morbid picture) cannot be learned from one single patient, but is only to be perfectly deduced (abstracted) and ascertained from the sufferings of several patients of different constitutions.

    1 The physician who has already, in the first cases, been able to choose a remedy approximating to the homœopathic specific, will, from the subsequence cases, be enabled either to verify the suitableness of the medicine chosen, or to discover a more appropriate, the most appropriate homœopathic remedy.

Homeopathic Individualized Q-potencies versus Fluoxetine for Moderate to Severe Depression: Double-blind, Randomized Non-inferiority Trial

Thursday 20 August, 2009

Homeopathic Individualized Q-potencies versus Fluoxetine for
Moderate to Severe Depression: Double-blind, Randomized
Non-inferiority Trial

U. C. Adler, N. M. P. Paiva, A. T. Cesar, M. S. Adler, A. Molina, A. E. Padula
and H. M. Calil
Faculdade de Medicina de Jundiaı ´, Homeopathy Graduation Programme, Department of Psychobiology,
Universidade Federal de Sa ˜ o Paulo, Sa ˜ o Paulo, Brazi

Homeopathy is a complementary and integrative medicine used in depression, The aim of this study is to investigate the non-inferiority and tolerability of individualized homeopathic medicines [Quinquagintamillesmial (Q-potencies)] in acute depression, using fluoxetine as active control. Ninety-one outpatients with moderate to severe depression were assigned to receive an individualized homeopathic medicine or fluoxetine 20mg day–1(up to 40mg day–1) in a pro-
spective, randomized, double-blind double-dummy 8-week, single-center trial. Primary efficacy measure was the analysis of the mean change in the Montgomery & Asberg Depression Rating  Scale (MADRS) depression scores, using a non-inferiority test with margin of 1.45. Secondary  efficacy outcomes were response and remission rates. Tolerability was assessed with the side
effect rating scale of the Scandinavian Society of Psychopharmacology. Mean MADRS scores  differences were not significant at the 4th (P¼0.654) and 8th weeks (P¼0.965) of treatment.  Non-inferiority of homeopathy was indicated because the upper limit of the confidence interval (CI) for mean difference in MADRS change was less than the non-inferiority margin: mean differences (homeopathy–fluoxetine) were 3.04 (95% CI 6.95, 0.86) and 2.4 (95% CI 6.05, 0.77) at 4th and 8th week, respectively. There were no significant differences between the percentages of response or remission rates in both groups. Tolerability: there were no significant differences between the side effects rates, although a higher percentage of patients treated with fluoxetine reported troublesome side effects and there was a trend toward greater
treatment interruption for adverse effects in the fluoxetine group. This study illustrates the feasibility of randomized controlled double-blind trials of homeopathy in depression and indicates the non-inferiority of individualized homeopathic Q-potencies as compared to fluoxetine in acute treatment of outpatients with moderate to severe depression.


Keywords: depression – drug therapy – fluoxetine – homeopathy – integrative and
alternative medicine – non-inferiority – Q-potencies – randomized controlled trial – remission –
response

Source :

               http://ecam.oxfordjournals.org/ 

               www.drptandon.blogspot.com 

Download :

                      Link 1

                      Link 2

Digg This